News / Press Releases - April 16, 2025
16 April 2025, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more
Member Spotlight - February 19, 2025
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Sarah Boyce, President and Chief Executive Officer at Avidity Biosciences. Tell us about your… read more
EUCOPE Resources / News - February 11, 2025
EUCOPE’s Sounds of Science Podcast – Episode 19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions In this episode of Sounds of Science, we invited our members, Toon Digneffe and Enrico Piccinini, to discuss with Alexander Natz how the EU’s competitiveness strategies may… read more
Member Spotlight - January 31, 2025
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In January, we spoke with Antoine Bernasconi, Executive VP, Chief Commercial Officer Europe & International at SERB Phamaceuticals. Tell… read more
Member Spotlight / News - December 19, 2024
Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the December edition, we spoke with Catherine Owen Adams, CEO of Acadia Pharmaceuticals. Tell us about your organization and… read more
News / Partnerships / Press Releases - May 17, 2024
On 16 May 2024, EUCOPE signed EURORDIS Open Letter #ActRare2024, during the Closing Plenary session of the 12th European Conference on Rare Diseases and Orphan Products (ECRD), organised in Brussels on 15-16 May 2024. The Open Letter is a result of, and informed by, the… read more
EUCOPE Resources / News - May 6, 2024
EUCOPE’s Sounds of Science Podcast – Episode 18 The Revision of the General Pharmaceutical Legislation: European Parliament Reports In this episode of Sounds of Science, we explore the ongoing Revision of the General Pharmaceutical Legislation (GPL). On 10 April, the European Parliament adopted their reports… read more
News / Press Releases - April 24, 2024
On 24 April 2024, the European Parliament adopted the provisional agreement on the European Health Data Space (EHDS) Regulation. The compromise text was already endorsed by COREPER on 22 March, but still requires formal adoption by the Employment, Social Policy, Health and Consumer Affairs Council… read more
News / Press Releases - April 11, 2024
On 10 April 2024, the European Parliament adopted the two reports on the Revision of the EU General Pharmaceutical Legislation, namely the Directive on medicinal products for human use and the Regulation on authorisation and supervision of medicinal products for human use and governing rules… read more
News / Press Releases - March 19, 2024
on ENVI reports on the EU Pharmaceutical Package Today, 19 March 2024, the European Parliament’s Committee on the Environment, Public Health and Food Safety (ENVI) adopted the two reports on the so-called EU Pharmaceutical Package, namely the Directive on Medicinal products for human use and… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information